Celularity Inc. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-01-23: Form PRE 14A; Period of report 2024-01-23; Description Preliminary proxy statement; Document formpre14a.htm.
- 2023-04-21: Form PRE 14A; Period of report 2023-06-14; Description PRE 14A; Document d484792dpre14a.htm.
- 2021-03-29: Form PRE 14A; Period of report 2021-03-29; Description PROXY; Document pre14a0321_gxacquisition.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-01-23 | PRE 14A | 2024-01-23 | Preliminary proxy statement | formpre14a.htm |
| 2023-04-21 | PRE 14A | 2023-06-14 | PRE 14A | d484792dpre14a.htm |
| 2021-03-29 | PRE 14A | 2021-03-29 | PROXY | pre14a0321_gxacquisition.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |